Literature DB >> 7906051

Tracking of markers and onset of disease among HIV-1 seroconverters.

N Galai1, A Muñoz, K Chen, V J Carey, J Chmiel, S Y Zhou.   

Abstract

Repeated measurements on persons infected with HIV-1 indicate that infection has a dynamic impact on several markers of immune suppression and activation. The objectives of this report are: (a) to provide a statistical model for the correlation structure of serial measurements of immunological markers, and (b) to identify features of marker profiles associated with the timing of AIDS diagnoses. We analyse data obtained from 328 seroconverters participating in the Multicenter AIDS Cohort Study on whom the date of HIV-1 seroconversion is known within +/- 4.5 months. Immunological markers considered here are CD4 cell counts, serum beta 2-microglobulin and serum neopterin. The statistical model for HIV-related changes in markers consists of (1) a piecewise linear regression model for the trajectories of markers over time and (2) a two-parameter autocorrelation function that generalizes Markovian and simple random effects autocorrelation structures. Application of this model for marker measurements revealed a high degree of tracking, as the estimated autocorrelation function exhibited sub-exponential decay over time. Though current marker levels are most informative on future values, there is substantial information (memory) in previous measurements. A feature suggested by the analysis of groups formed according to the length of the AIDS-free period, is the sequential divergence of the CD4 trajectories where steeper declines occurred with a two-year lag prior to AIDS onset. For AIDS cases diagnosed 3-5 and 5-7 years after seroconversion, the rates of decline compared with those free of AIDS for at least 4 years were steeper by 95 and 46 per cent respectively at two years prior to AIDS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7906051     DOI: 10.1002/sim.4780122207

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  5 in total

1.  Early levels of CD4, neopterin, and beta 2-microglobulin indicate future disease progression.

Authors:  M Shi; J M Taylor; J L Fahey; D R Hoover; A Muñoz; L A Kingsley
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

Review 2.  Critical analysis of the current views on the nature of AIDS.

Authors:  V L Koliadin
Journal:  Genetica       Date:  1995       Impact factor: 1.082

3.  Identification of inflections in T-cell counts among HIV-1-infected individuals and relationship with progression to clinical AIDS.

Authors:  S J Gange; A Muñoz; J S Chmiel; A D Donnenberg; L M Kirstein; R Detels; J B Margolick
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

4.  Multiplex assay reliability and long-term intra-individual variation of serologic inflammatory biomarkers.

Authors:  Heather S McKay; Joseph B Margolick; Otoniel Martínez-Maza; Joseph Lopez; John Phair; Giovanna Rappocciolo; Thomas N Denny; Larry I Magpantay; Lisa P Jacobson; Jay H Bream
Journal:  Cytokine       Date:  2016-12-09       Impact factor: 3.861

5.  Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection.

Authors:  A N Phillips; C A Sabin; J Elford; M Bofill; G Janossy; C A Lee
Journal:  BMJ       Date:  1994-07-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.